Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic; Functional Disturbance”

153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 153 results

Not applicableUnknownNCT03713606
What this trial is testing

Serum Biomarkers for Portal Hypertension in Cirrhosis (Pan-CHESS1802)

Who this might be right for
Hypertension, Portal
Nanfang Hospital, Southern Medical University 75
Testing effectiveness (Phase 2)Study completedNCT00867698
What this trial is testing

AST-120 Used to Treat Mild Hepatic Encephalopathy

Who this might be right for
Mild Hepatic Encephalopathy
Ocera Therapeutics 148
Early research (Phase 1)Study completedNCT01367522
What this trial is testing

Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone in Volunteers With Impaired Hepatic Function

Who this might be right for
Liver Dysfunction
Bausch Health Americas, Inc. 24
Not applicableNot Yet RecruitingNCT07270822
What this trial is testing

Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes

Who this might be right for
Steatotic Liver DiseaseFibrosis of Liver
Hospices Civils de Lyon 1,714
Not applicableUnknownNCT02850692
What this trial is testing

Portal Hypertension and Systemic Endothelial Function

Who this might be right for
Cystic FibrosisPortal Hypertension
Hopital Foch 60
Early research (Phase 1)Study completedNCT01392807
What this trial is testing

Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function

Who this might be right for
Hepatic; Functional Disturbance
AstraZeneca 24
Not applicableStudy completedNCT01490203
What this trial is testing

Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma

Who this might be right for
Carcinoma, HepatocellularLiver Dysfunction
Seoul National University Hospital 71
Not applicableUnknownNCT02893657
What this trial is testing

The Role and Dynamics of Liver Dysfunction in Patients Undergoing Cardiac Surgery

Who this might be right for
Cardiac SurgeryHepatic ImpairmentHeart Failure
Semmelweis University Heart and Vascular Center 150
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Not applicableStudy completedNCT04890860
What this trial is testing

Detection of Right Ventricular Dysfunction by Portal Vein Doppler After Cardiac Surgery

Who this might be right for
Postoperative ComplicationsHeart DiseasesHeart Failure+1 more
CMC Ambroise Paré 70
Early research (Phase 1)Study completedNCT05700695
What this trial is testing

Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)

Who this might be right for
Hepatic EncephalopathyAcute-On-Chronic Liver Failure
Post Graduate Institute of Medical Education and Research, Chandigarh 114
Not applicableNot Yet RecruitingNCT07412444
What this trial is testing

EVOO and Metabolic Liver Health in MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseOverweight
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 60
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Not applicableStudy completedNCT01002261
What this trial is testing

Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects

Who this might be right for
Liver Cirrhosis
Aarhus University Hospital 16
Not applicableStudy completedNCT01000337
What this trial is testing

Markers of Liver Apoptosis After Anesthesia With Sevoflurane or Propofol

Who this might be right for
Liver Dysfunction
University of Athens 67
Early research (Phase 1)Study completedNCT01571388
What this trial is testing

Compare Pharmacokinetics Of Dacomitinib (PF-00299804) Between Healthy Subjects And Subjects With Mild And Moderate Hepatic Impairment

Who this might be right for
HealthyOtherwise Healthy Volunteers With Mild or Moderate Hepatic Dysfunction
Pfizer 25
Testing effectiveness (Phase 2)Study completedNCT01394497
What this trial is testing

Use of N-Acetylcysteine During Liver Procurement

Who this might be right for
Liver FailureLiver Failure, AcuteLiver Diseases+2 more
Azienda Ospedaliera di Padova 140
Not applicableStudy completedNCT03833297
What this trial is testing

Monitoring the HePAtological TOXicity of Drugs (HePATOX)

Who this might be right for
Liver DiseasesLiver DysfunctionLiver Failure+1 more
Groupe Hospitalier Pitie-Salpetriere 1,000
Large-scale testing (Phase 3)UnknownNCT05595109
What this trial is testing

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Who this might be right for
Breast CancerPeripheral NeuropathyCardiac Toxicities+2 more
Tanta University 56
Not applicableStudy completedNCT01201720
What this trial is testing

Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"

Who this might be right for
Liver CirrhosisLiver Failure
Instituto Grifols, S.A. 12
Load More Results